Figure Gallery

Expression Pattern Search Results for runx1

(401 figures with expression from 192 publications)

[ Show only figures with images ]
Publication	Data	Fish	Condition	Stage Range	Anatomy
Lim et al., 2017	Fig. 3	WT WT + MO1-hif1ab	control	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 4	WT WT + MO1-il6	control	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 5	WT WT + MO1-il6	control chemical treatment by environment: cobalt dichloride	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 2	WT WT + MO1-pdgfrb WT + MO2-vhl WT + MO1-pdgfrb + MO2-vhl	control chemical treatment by environment: dimethyloxalylglycine	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 1	WT	control chemical treatment by environment: cobalt dichloride, chemical treatment by environment: EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor chemical treatment by environment: cobalt dichloride chemical treatment by environment: EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
Lin et al., 2017	Fig. 1	mpl^sm10/sm10 (AB)	standard conditions	Adult	head kidney
Lu et al., 2017	Fig. 2	AB twu104Tg (AB)	standard conditions	20-25 somites to Day 5	whole organism
Manesia et al., 2017	Fig. 5	WT + MO1-uhrf1 WT + MO2-ncoa1 WT + MO2-tdg.1 WT + MO2-uchl5	standard conditions	Prim-25	ventral wall of dorsal aorta
Theodore et al., 2017	Fig. 2	WT WT + MO1-mmp2 WT + MO4-mmp9	control chemical treatment by environment: N(2)-([biphenyl]-4-ylsulfonyl)-N-hydroxy-N(2)-isopropoxy-D-valinamide chemical treatment by environment: prinomastat hydrochloride chemical treatment by environment: MMP9 inhibitor I	Prim-25	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. 1	WT	chemical treatment by environment: indometacin chemical treatment by environment: CAY10397	High-pec	whole organism
Wang et al., 2017	Fig. 5	WT WT + MO1-adtrp2 WT + MO1-adtrp1 + MO1-adtrp2	standard conditions control	Prim-15	hematopoietic stem cell
	Fig. 3	WT WT + MO1-adtrp1	standard conditions control	Prim-15	hematopoietic stem cell
	Fig. 6	WT WT + MO1-adtrp1	standard conditions control	Prim-15	hematopoietic stem cell
	Fig. 7	WT WT + MO1-adtrp1	standard conditions control	Prim-15	hematopoietic stem cell
Xu et al., 2017	Fig. 2	WT	standard conditions	Prim-5	hematopoietic multipotent progenitor cell
Zhang et al., 2017	Fig. 3	TU TU + MO1-mettl3 TU + MO1-mettl3 + MO1-notch1a	standard conditions chemical treatment: LY-411575	Prim-5	whole organism
Zhang et al., 2017	Fig. 1	WT tgfb1b^{zf2126/zf2126}	standard conditions	Prim-15	hematopoietic stem cell ventral wall of dorsal aorta
	Fig. 2	WT tgfb1b^{zf2126/zf2126}	standard conditions	Prim-15	hematopoietic stem cell ventral wall of dorsal aorta
	Fig. 4	TU WT tgfb1b^{zf2126/zf2126}	standard conditions control chemical treatment: anthra[1,9-cd]pyrazol-6(2H)-one	Prim-15	hematopoietic stem cell ventral wall of dorsal aorta
	Fig. 6	WT tgfb1b^{zf2126/zf2126} WT + MO1-g6pc3	control standard conditions chemical treatment: glucose	Prim-15	hematopoietic stem cell ventral wall of dorsal aorta
Chen et al., 2016	Fig. 1	WT WT + MO1-cyp2aa3,cyp2aa9	standard conditions	Prim-5 to Prim-25	dorsal aorta hematopoietic stem cell
Cortes et al., 2016	Fig. 1	WT vdra^zf735/zf735 WT + MO2-vdra	standard conditions	Prim-25	ventral wall of dorsal aorta whole organism
De La Garza et al., 2016	Fig. 4	WT sf3b1^{hi3394aTg/hi3394aTg}	standard conditions	Prim-5	ventral wall of dorsal aorta hematopoietic stem cell
Gao et al., 2016	Fig. 4	WT WT + MO1-gpr65 WT + MO2-gpr65	control	Prim-25	hematopoietic multipotent progenitor cell
Han et al., 2016	Fig. 5	WT WT + MO1-hal WT + MO1-mettl22 WT + MO2-ap2a1 WT + MO2-prdm16 WT + MO3-lrsam1	standard conditions control	Prim-5	ventral wall of dorsal aorta hematopoietic stem cell